abstract |
The present invention relates to 5,6-dihydro-4H- [1,3] oxazin-2-ylamine compounds of formula (I) as well as pharmaceutically acceptable salts thereof. The compound is a BACE2 inhibitor and can be used, for example, as a medicament for the treatment or prevention of diseases such as diabetes. (I) Wherein R 1 to R 5 are as defined in the specification and claims. |